Publisher: Julio Licinio, MD, PhD, MBA, MS.
https://genomicpress.com/
https://media.genomicpress.com/
Nature just dropped a bombshell feature on Brazil's supercentenarians: people hitting 110+ without elite diets, gyms, or fancy meds. Their secret? Genes + insane resilience. And the groundbreaking research behind it? Published in Genomic Psychiatry
🔗 www.nature.com/articles/d41...
Nature just dropped a bombshell feature on Brazil's supercentenarians: people hitting 110+ without elite diets, gyms, or fancy meds. Their secret? Genes + insane resilience. And the groundbreaking research behind it? Published in Genomic Psychiatry
🔗 www.nature.com/articles/d41...
BREAKING from Genomic Psychiatry: The future of mental health research is HERE! Introducing Genomic Psychiatry 2025: Entire Volume 1: Our revolutionary open-access e-book compiling a FULL YEAR of groundbreaking discoveries. This 434-page powerhouse is FREE to everyone, everywhere!
BREAKING from Genomic Psychiatry: The future of mental health research is HERE! Introducing Genomic Psychiatry 2025: Entire Volume 1: Our revolutionary open-access e-book compiling a FULL YEAR of groundbreaking discoveries. This 434-page powerhouse is FREE to everyone, everywhere!
🧠 ALZHEIMER'S BREAKTHROUGH IN BRAIN MEDICINE: What if we've been targeting the wrong AMPK in Alzheimer's treatments? New mini-review reveals two isoforms with OPPOSITE effects: one harms, one helps. This could rewrite drug strategies. Scroll the thread!
#Alzheimers #Neuroscience
🧠 ALZHEIMER'S BREAKTHROUGH IN BRAIN MEDICINE: What if we've been targeting the wrong AMPK in Alzheimer's treatments? New mini-review reveals two isoforms with OPPOSITE effects: one harms, one helps. This could rewrite drug strategies. Scroll the thread!
#Alzheimers #Neuroscience
🧠🧬The Brazilian Supercentenarians 🧓 are now featured in:
Discover magazine: url.genomicpress.com/3xxc544d
Science Daily: url.genomicpress.com/2p85e6b7
and this was the most read article in O Globo: url.genomicpress.com/2p97k5y7
Can we live to 120?
Time will tell!
Source: doi.org/10.61373/gp0...
🧠🧬The Brazilian Supercentenarians 🧓 are now featured in:
Discover magazine: url.genomicpress.com/3xxc544d
Science Daily: url.genomicpress.com/2p85e6b7
and this was the most read article in O Globo: url.genomicpress.com/2p97k5y7
Can we live to 120?
Time will tell!
Source: doi.org/10.61373/gp0...
Our new Genomic Psychiatry Viewpoint on Brazilian supercentenarians is exploding! Front-page in Folha, Estadão, O Globo & El País. Brazil's genetic admixture may unlock secrets to extreme longevity.
🌐 Source: genomicpress.com
Our new Genomic Psychiatry Viewpoint on Brazilian supercentenarians is exploding! Front-page in Folha, Estadão, O Globo & El País. Brazil's genetic admixture may unlock secrets to extreme longevity.
🌐 Source: genomicpress.com
The prisoner dares defy research orthodoxy.
Watch what happens when the prisoner escapes the institutional-funding-publishing establishment, and what happens to DOGMA as that happens.
(Hint: the journey down is part of the point)
URL: genomicpress.com
The prisoner dares defy research orthodoxy.
Watch what happens when the prisoner escapes the institutional-funding-publishing establishment, and what happens to DOGMA as that happens.
(Hint: the journey down is part of the point)
URL: genomicpress.com
🧠 THIS JUST BROKE THE INTERNET IN ALZHEIMER’S RESEARCH
A brand-new paper (published 3 days ago) shows we had tau completely wrong.
The enzyme **OTULIN** doesn’t just control inflammation…
It CONTROLS WHETHER YOUR BRAIN EVEN MAKES TAU PROTEIN.
Link: doi.org/10.61373/gp0...
🧠 THIS JUST BROKE THE INTERNET IN ALZHEIMER’S RESEARCH
A brand-new paper (published 3 days ago) shows we had tau completely wrong.
The enzyme **OTULIN** doesn’t just control inflammation…
It CONTROLS WHETHER YOUR BRAIN EVEN MAKES TAU PROTEIN.
Link: doi.org/10.61373/gp0...
Unprecedented. Global. Transformative.
100+ Exclusive Interviews • Academy Members to Rising Stars • 20+ Countries
Unprecedented. Global. Transformative.
100+ Exclusive Interviews • Academy Members to Rising Stars • 20+ Countries
4000+ news stories worldwide in 35+ languages.
Social media reach: 12+M
Unprecedented global coverage for a new Open Access Publisher: NY Times, Washington Post, CNN, AP, Newsweek, Discover, Daily Mail, FAZ, SZ, SCMP, El País, 163.com
media.genomicpress.com
Submit your work!
4000+ news stories worldwide in 35+ languages.
Social media reach: 12+M
Unprecedented global coverage for a new Open Access Publisher: NY Times, Washington Post, CNN, AP, Newsweek, Discover, Daily Mail, FAZ, SZ, SCMP, El País, 163.com
media.genomicpress.com
Submit your work!
☕🧠 THE COFFEE PARADOX IN DEPRESSION TREATMENT
New Brain Medicine commentary highlights Nature research revealing adenosine as the master regulator of rapid antidepressant action—creating a fascinating clinical dilemma.
Our analysis: dx.doi.org/10.61373/bm0...
Nature: doi.org/10.1038/s415...
☕🧠 THE COFFEE PARADOX IN DEPRESSION TREATMENT
New Brain Medicine commentary highlights Nature research revealing adenosine as the master regulator of rapid antidepressant action—creating a fascinating clinical dilemma.
Our analysis: dx.doi.org/10.61373/bm0...
Nature: doi.org/10.1038/s415...
(1/8)
(1/8)
🔬 First time ever: Peer-reviewed study by Soreq's group shows neurons survive botulinum via 335 protective RNA fragments in human cells. 20% share identical motif blocking ferroptosis. Changes treatment possibilities.
Read: doi.org/10.61373/gp0...
Source: genomicpress.kglmeridian.com
🔬 First time ever: Peer-reviewed study by Soreq's group shows neurons survive botulinum via 335 protective RNA fragments in human cells. 20% share identical motif blocking ferroptosis. Changes treatment possibilities.
Read: doi.org/10.61373/gp0...
Source: genomicpress.kglmeridian.com
🧠 Access all our neuroscience research in one convenient spot - perfect for reading on your phone:
Built for seamless mobile browsing, fast loading, and easy navigation. Check it out and let us know what you think! 💡📖
🔗 bm.genomicpress.com
🧠 Access all our neuroscience research in one convenient spot - perfect for reading on your phone:
Built for seamless mobile browsing, fast loading, and easy navigation. Check it out and let us know what you think! 💡📖
🔗 bm.genomicpress.com
🇲🇽 El País feature article (Spanish—use browser translation tools): elpais.com/mexico/2025-...
#MentalHealth
🇲🇽 El País feature article (Spanish—use browser translation tools): elpais.com/mexico/2025-...
#MentalHealth
🔓🆓 OPEN ACCESS Genomic Press Interview (in-depth scientific discussion): doi.org/10.61373/bm0...
🔓🆓 OPEN ACCESS Genomic Press Interview (in-depth scientific discussion): doi.org/10.61373/bm0...
🔓🆓 doi.org/10.61373/gp0...
Genomic Press: genomicpress.kglmeridian.com
🔓🆓 doi.org/10.61373/gp0...
Genomic Press: genomicpress.kglmeridian.com
🔓🆓 OPEN ACCESS: doi.org/10.61373/bm0...
🌐 Source: genomicpress.kglmeridian.com
🔓🆓 OPEN ACCESS: doi.org/10.61373/bm0...
🌐 Source: genomicpress.kglmeridian.com
✨ Light at night can disrupt sleep 💤, weaken immunity 🦠, affect mood (depression & anxiety 😔), and increase obesity 🍟.
🌎 News story: qazaqscience.kz/archives/2722
🔓🆓 OPEN ACCESS interview: doi.org/10.61373/bm0...
✨ Light at night can disrupt sleep 💤, weaken immunity 🦠, affect mood (depression & anxiety 😔), and increase obesity 🍟.
🌎 News story: qazaqscience.kz/archives/2722
🔓🆓 OPEN ACCESS interview: doi.org/10.61373/bm0...
🧠 Psychodeliki i terapia? Badania sugerują, że to może się udać
🔬 Psychedelics and therapy? Research suggests it might work
💊🧬
🔓🆓 Open Access: doi.org/10.61373/pp0...
ℹ️ Genomic Press: genomicpress.kglmeridian.com
🧠 Psychodeliki i terapia? Badania sugerują, że to może się udać
🔬 Psychedelics and therapy? Research suggests it might work
💊🧬
🔓🆓 Open Access: doi.org/10.61373/pp0...
ℹ️ Genomic Press: genomicpress.kglmeridian.com
🔓🆓 Open Access Article: doi.org/10.61373/pp0...
More breakthroughs at Genomic Press: genomicpress.kglmeridian.com
🔓🆓 Open Access Article: doi.org/10.61373/pp0...
More breakthroughs at Genomic Press: genomicpress.kglmeridian.com
🔓🆓Open Access Interview: doi.org/10.61373/bm0...
More about Genomic Press: genomicpress.kglmeridian.com
🔓🆓Open Access Interview: doi.org/10.61373/bm0...
More about Genomic Press: genomicpress.kglmeridian.com
🔓🆓 Interview: doi.org/10.61373/pp0...
Source: genomicpress.kglmeridian.com
🔓🆓 Interview: doi.org/10.61373/pp0...
Source: genomicpress.kglmeridian.com
📄🆓 Open Access: doi.org/10.61373/pp0...
🌐 Discover more at: genomicpress.kglmeridian.com
📄🆓 Open Access: doi.org/10.61373/pp0...
🌐 Discover more at: genomicpress.kglmeridian.com
📄🆓 Open Access: doi.org/10.61373/gp0...
🌐 Discover more at Genomic Press: genomicpress.kglmeridian.com
📄🆓 Open Access: doi.org/10.61373/gp0...
🌐 Discover more at Genomic Press: genomicpress.kglmeridian.com
📄 Open Access Genomic Press Interview: doi.org/10.61373/bm0...
🌐 Source: genomicpress.kglmeridian.com
📄 Open Access Genomic Press Interview: doi.org/10.61373/bm0...
🌐 Source: genomicpress.kglmeridian.com